相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antidiabetic drug pioglitazone protects the heart via activation of PPAR-γ receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction
Shinji Yasuda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
MicroRNA-320 Is Involved in the Regulation of Cardiac Ischemia/Reperfusion Injury by Targeting Heat-Shock Protein 20
Xiao-Ping Ren et al.
CIRCULATION (2009)
Downregulation of MiR-199a Derepresses Hypoxia-Inducible Factor-1α and Sirtuin 1 and Recapitulates Hypoxia Preconditioning in Cardiac Myocytes
Shweta Rane et al.
CIRCULATION RESEARCH (2009)
A Novel Role of MicroRNA in Late Preconditioning Upregulation of Endothelial Nitric Oxide Synthase and Heat Shock Protein 70
Chang Yin et al.
CIRCULATION RESEARCH (2009)
miR-29 miRNAs activate p53 by targeting p85a and CDC42
Seong-Yeon Park et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Angelika Bonauer et al.
SCIENCE (2009)
The role of eNOS, iNOS, and NF-κB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Oral Glyburide, But Not Glimepiride, Blocks the Infarct-Size Limiting Effects of Pioglitazone
Yumei Ye et al.
CARDIOVASCULAR DRUGS AND THERAPY (2008)
The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure
Vijay Divakaran et al.
CIRCULATION RESEARCH (2008)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
Eva van Rooij et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNAs in the broken heart
J. Bauersachs et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
mir-29 regulates Mcl-1 protein expression and apoptosis
J. L. Mott et al.
ONCOGENE (2007)
MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets
Eva Van Rooij et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
MicroRNAs in the human heart - A clue to fetal gene reprogramming in heart failure
Thomas Thum et al.
CIRCULATION (2007)
The late phase of ischemic preconditioning induces a prosurvival genetic program that results in marked attenuation of apoptosis
Adam B. Stein et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Control of stress-dependent cardiac growth and gene expression by a microRNA
Eva van Rooij et al.
SCIENCE (2007)
The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2
Baofeng Yang et al.
NATURE MEDICINE (2007)
MicroRNAs play an essential role in the development of cardiac hypertrophy
Danish Sayed et al.
CIRCULATION RESEARCH (2007)
Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions
Yumei Ye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Pioglitazone but not glibenclamide improves cardiac expression of heat shock protein 72 and tolerance against ischemia/reperfusion injury in the heredity insulin-resistant rat
Yayoi Taniguchi et al.
DIABETES (2006)
Pioglitazone mimics preconditioning in the isolated perfused rat heart - A role for the prosurvival kinases PI3K and P42/44MAPK
AM Wynne et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
I Shiojima et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury
T Nagoshi et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Laminar flow activates peroxisome proliferator-activated receptor-γ in vascular endothelial cells
Y Liu et al.
CIRCULATION (2004)
Microfluidic PicoArray synthesis of oligodeoxynucleotides and simultaneous assembling of multiple DNA sequences
XC Zhou et al.
NUCLEIC ACIDS RESEARCH (2004)
Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates myocardial ischernia/reperfusion injury in a rat model
H Ito et al.
LABORATORY INVESTIGATION (2003)
Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors
CH Lee et al.
ENDOCRINOLOGY (2003)
Ligands of the peroxisome proliferator-activated receptors (PPAR-γ and PPAR-α) reduce myocardial infarct size
NS Wayman et al.
FASEB JOURNAL (2002)
Dynamic progression of contractile and endothelial dysfunction and infarct extension in the late phase of reperfusion
ZQ Zhao et al.
JOURNAL OF SURGICAL RESEARCH (2000)
分享论文
